EOM. Bankrupt in 1 year.
Let's keep this thread alive then and come back in 2 years. Anyone who shorts this stock will make money. Buy and hold will continue to lose money. So many suckers on here listen to all these pumpers.
Once Phase 3 ends, Inovio will go bankrupt. VGX-3100 is already obsolete. Genexine’s GX-188E DNA vaccine shows the highest efficacy 78% compared to Invio's VGX-3100 40% in CIN3 regression trial.
Vgx 3100 data was released long ago and did not impress me one bit. A little less than half of the hpv placebo controll group cured themselves without inovio treatment. Inovio's treatment only made 10% difference. Very short of a breakthrough treatment.
This company will receive FDA fast track status on two candidates: INO-5150 and INO-1400.
Sentiment: Strong Buy